The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company’s financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.
Price action
With a market capitalization of Rs. 656.04 crores on Friday, the shares of Sudarshan Pharma Industries Ltd. were trading at CMP 27.80, which is close to 2 percent higher than its previous day’s closing price of Rs 27.26. The stock hit a 2 percent upper circuit today.
What Happened
Sudarshan Pharma Industries Ltd, a company engaged in the manufacturing of API and Pharmaceutical Items. , has announced its results for the Financial year ‘25.
Its Revenue grew by 20 percent YoY from Rs. 232 Crores in Q4FY24 to Rs. 277 Crores in Q4FY25, and it grew by 21.5 percent QoQ from Rs. 228 Crores in Q3FY25 to Rs. 277 Crores in Q4FY25.
Its Net Profit grew by 50 percent YoY from Rs. 6.60 Crores in Q4FY24 to Rs. 10 Crores in Q4FY25, but this includes an exponential income worth 1.65 crores obtained from the sale of an extended producer responsibility certificate. Excluding the exponential item, the net profit growth stands at 43 percent Year on year. The Net profits have grown by 70 percent QoQ from Rs. 5.92 Crores in Q3FY25 to Rs. 10 Crores in Q4FY25.
The company’s Earnings Before Interest, Depreciation, and Taxes (EBIDT) has also grown by 62 percent YOY from Rs 14.4 in Q4FY24 to Rs 23.4 in Q4FY25. Its EPS has also grown by 56 percent YOY from Rs. 0.27 in Q4FY24 to Rs. 0.42 in Q4FY25, and has increased by 68 percent QoQ from Rs. 0.25 in Q3FY25 to Rs. 0.42 in Q4FY25.
About the company
Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents. The Company carries Ethical marketing of Pharmaceutical formulation & products in the Domestic and International markets through a distribution network and Sales force under its own brand.
It is also involved in Contract Manufacturing, outsourcing, & Supply of Generic Pharma formulation and medicines to healthcare institutions, Government, NGO, and Hospitals. It also offers services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing innovative products as per their needs.
Written by Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
